Early Blood Glucose Screening in Asymptomatic High-risk Neonates
Detecting and treating severe hypoglycemia promptly after birth is crucial due to its association with adverse long-term neurodevelopmental outcomes. However, limited data are available on the optimal timing of glucose screening in asymptomatic high-risk neonates prone to hypoglycemia. This webinar will address the incidence and the impact of individual risk factors on early hypoglycemia in asymptomatic high-risk neonates. Dr. Hanna will also discuss the importance of blood glucose screening in the first hour of life to help identify early severe neonatal hypoglycemia.
Presenter:
Dr. Nazeeh Hanna, M.D. Professor, Department of Pediatrics at NYU Grossman Long Island School of Medicine Chief, Neonatology, NYU Langone Hospital
Presenter:
Dennis Begos, MD, FACS, FACRS Senior Director Medical and Scientific Affairs Nova Biomedical